Aurora Cannabis and Mitacs to Fund Research Project on Health and Economic Outcomes of Cannabis-Based Therapies

Visit the Aurora Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

EDMONTON, April 30, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company and Mitacs, a national, not-for-profit research and training organization, have partnered to fund a University of Alberta research program studying the health outcomes associated with cannabis use.

Despite a rapidly growing body of scientific and anecdotal evidence supporting the therapeutic benefits of cannabis, comprehensive patient cohort studies into health outcomes related to cannabis use are lacking. Consequently, many physicians who are attempting to accommodate

... read more at: